-
1
-
-
46449084158
-
Molecular imaging in drug development
-
Willmann JK, van Bruggen N, Dinkelborg LM, Gambhir SS. Molecular imaging in drug development. Nat Rev Drug Discov. 2008;7(7):591-607.
-
(2008)
Nat Rev Drug Discov
, vol.7
, Issue.7
, pp. 591-607
-
-
Willmann, J.K.1
van Bruggen, N.2
Dinkelborg, L.M.3
Gambhir, S.S.4
-
2
-
-
78650394438
-
Molecular tracers for the PET and SPECT imaging of disease
-
Pimlott SL, Sutherland A. Molecular tracers for the PET and SPECT imaging of disease. Chem Soc Rev. 2011;40(1):149-62.
-
(2011)
Chem Soc Rev
, vol.40
, Issue.1
, pp. 149-162
-
-
Pimlott, S.L.1
Sutherland, A.2
-
3
-
-
0036392074
-
Positron emission tomography: Imaging and quantification of neurotransporter availability
-
Laruelle M, Slifstein M, Huang Y. Positron emission tomography: imaging and quantification of neurotransporter availability. Methods. 2002;27(3):287-99.
-
(2002)
Methods
, vol.27
, Issue.3
, pp. 287-299
-
-
Laruelle, M.1
Slifstein, M.2
Huang, Y.3
-
4
-
-
77956189401
-
Radiopharmaceuticals for positron emission tomography investigations of Alzheimer's disease
-
Någren K, Halldin C, Rinne JO. Radiopharmaceuticals for positron emission tomography investigations of Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2010;37(8):1575-93.
-
(2010)
Eur J Nucl Med Mol Imaging
, vol.37
, Issue.8
, pp. 1575-1593
-
-
Någren, K.1
Halldin, C.2
Rinne, J.O.3
-
5
-
-
36749062430
-
Molecular and cellular mechanisms for Alzheimer's disease: Understanding APP metabolism
-
Zhang Y-wu, Xu H. Molecular and cellular mechanisms for Alzheimer's disease: understanding APP metabolism. Curr Mol Med. 2007;7(7):687-96.
-
(2007)
Curr Mol Med
, vol.7
, Issue.7
, pp. 687-696
-
-
Y-Wu, Z.1
Xu, H.2
-
6
-
-
10744232413
-
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
-
Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 2004;55(3):306-19.
-
(2004)
Ann Neurol
, vol.55
, Issue.3
, pp. 306-319
-
-
Klunk, W.E.1
Engler, H.2
Nordberg, A.3
Wang, Y.4
Blomqvist, G.5
Holt, D.P.6
-
9
-
-
66549106850
-
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: Implications for sequence of pathological events in Alzheimer's disease
-
Jack CR, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain. 2009;132(Pt 5):1355-65.
-
(2009)
Brain
, vol.132
, Issue.PART 5
, pp. 1355-1365
-
-
Jack, C.R.1
Lowe, V.J.2
Weigand, S.D.3
Wiste, H.J.4
Senjem, M.L.5
Knopman, D.S.6
-
10
-
-
33749506795
-
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
-
Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I et al. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain. 2006;129(Pt 11):2856-66.
-
(2006)
Brain
, vol.129
, Issue.PART 11
, pp. 2856-2866
-
-
Engler, H.1
Forsberg, A.2
Almkvist, O.3
Blomquist, G.4
Larsson, E.5
Savitcheva, I.6
-
11
-
-
34248579291
-
Imaging beta-amyloid burden in aging and dementia
-
Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G et al. Imaging beta-amyloid burden in aging and dementia. Neurology. 2007;68(20):1718-25.
-
(2007)
Neurology
, vol.68
, Issue.20
, pp. 1718-1725
-
-
Rowe, C.C.1
Ng, S.2
Ackermann, U.3
Gong, S.J.4
Pike, K.5
Savage, G.6
-
12
-
-
36849088537
-
In vivo amyloid imaging with PET in frontotemporal dementia
-
Engler H, Santillo AF, Wang SX, Lindau M, Savitcheva I, Nordberg A et al. In vivo amyloid imaging with PET in frontotemporal dementia. Eur J Nucl Med Mol Imaging. 2008;35(1):100-6.
-
(2008)
Eur J Nucl Med Mol Imaging
, vol.35
, Issue.1
, pp. 100-106
-
-
Engler, H.1
Santillo, A.F.2
Wang, S.X.3
Lindau, M.4
Savitcheva, I.5
Nordberg, A.6
-
13
-
-
4544335597
-
Mild cognitive impairment as a diagnostic entity
-
Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183-94.
-
(2004)
J Intern Med
, vol.256
, Issue.3
, pp. 183-194
-
-
Petersen, R.C.1
-
15
-
-
49349092320
-
PET imaging of amyloid deposition in patients with mild cognitive impairment
-
Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A et al. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol aging. 2008;29(10):1456-65.
-
(2008)
Neurobiol Aging
, vol.29
, Issue.10
, pp. 1456-1465
-
-
Forsberg, A.1
Engler, H.2
Almkvist, O.3
Blomquist, G.4
Hagman, G.5
Wall, A.6
-
16
-
-
70349582720
-
Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study
-
Okello A, Koivunen J, Edison P, Archer HA, Turkheimer FE, Någren K et al. Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology. 2009;73(10):754-60.
-
(2009)
Neurology
, vol.73
, Issue.10
, pp. 754-760
-
-
Okello, A.1
Koivunen, J.2
Edison, P.3
Archer, H.A.4
Turkheimer, F.E.5
Någren, K.6
-
18
-
-
84864005418
-
Brain amyloid and cognition in Lewy body diseases
-
Available from, [cited 2012 Jun 24]
-
Gomperts SN, Locascio JJ, Marquie M, Santarlasci AL, Rentz DM, Maye J et al. Brain amyloid and cognition in Lewy body diseases. Mov disord [Available from: http://www.ncbi.nlm.nih.gov/pubmed/22693110]. 2012 [cited 2012 Jun 24].
-
(2012)
Mov Disord
-
-
Gomperts, S.N.1
Locascio, J.J.2
Marquie, M.3
Santarlasci, A.L.4
Rentz, D.M.5
Maye, J.6
-
19
-
-
34848864297
-
In vitro characterization of Pittsburgh compound-B binding to Lewy bodies
-
Fodero-Tavoletti MT, Smith DP, McLean C a, Adlard P a, Barnham KJ, Foster LE et al. In vitro characterization of Pittsburgh compound-B binding to Lewy bodies. J Neurosci. 2007;27(39):10365-71.
-
(2007)
J Neurosci
, vol.27
, Issue.39
, pp. 10365-10371
-
-
Fodero-Tavoletti, M.T.1
Smith, D.P.2
McLean, C.A.3
Adlard, P.A.4
Barnham, K.J.5
Foster, L.E.6
-
20
-
-
41149127264
-
Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease
-
Kadir A, Andreasen N, Almkvist O, Wall A, Forsberg A, Engler H et al. Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease. Ann Neurol. 2008;63(5):621-31.
-
(2008)
Ann Neurol
, vol.63
, Issue.5
, pp. 621-631
-
-
Kadir, A.1
Andreasen, N.2
Almkvist, O.3
Wall, A.4
Forsberg, A.5
Engler, H.6
-
21
-
-
77249145936
-
18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's disease: A miniperspective
-
Kung HF, Choi SR, Qu W, Zhang W, Skovronsky D. 18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's disease: a miniperspective. J Med Chem. 2010;53(3):933-41.
-
(2010)
J Med Chem
, vol.53
, Issue.3
, pp. 933-941
-
-
Kung, H.F.1
Choi, S.R.2
Qu, W.3
Zhang W.Skovronsky, D.4
-
22
-
-
77956384880
-
8F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial
-
Vandenberghe R, Van Laere K, Ivanoiu A, Salmon E, Bastin C, Triau E et al. 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial. Ann Neurol. 2010;68(3):319-29.
-
(2010)
Ann Neurol
, vol.68
, Issue.3
, pp. 319-329
-
-
Vandenberghe, R.1
van Laere, K.2
Ivanoiu, A.3
Salmon, E.4
Bastin, C.5
Triau, E.6
-
23
-
-
77953937194
-
In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)
-
Wong DF, Rosenberg PB, Zhou Y, Kumar A, Raymont V, Ravert HT, et al. In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18). J Nucl Med. 2010;51(6):913-20.
-
(2010)
J Nucl Med
, vol.51
, Issue.6
, pp. 913-920
-
-
Wong, D.F.1
Rosenberg, P.B.2
Zhou, Y.3
Kumar, A.4
Raymont, V.5
Ravert, H.T.6
-
24
-
-
80055040100
-
Florbetaben to trace amyloid-β in the Alzheimer brain by means of PET
-
Barthel H, Sabri O. Florbetaben to trace amyloid-β in the Alzheimer brain by means of PET. J Alzheimers Dis. 2011;26(Suppl 3):117-21.
-
(2011)
J Alzheimers Dis
, vol.26
, Issue.SUPPL. 3
, pp. 117-121
-
-
Barthel, H.1
Sabri, O.2
-
25
-
-
84864535821
-
-
FDA Approves 18F-Florbetapir PET Agent
-
FDA Approves 18F-Florbetapir PET Agent. J Nucl Med. 2012;53(6):15N.
-
(2012)
J Nucl Med
, vol.53
, Issue.6
-
-
-
26
-
-
78751647972
-
99mTc- and Re-labeled 6-dialkylamino-2-naphthylethylidene derivatives as imaging probes for β-amyloid plaques
-
Cui M, Tang R, Li Z, Ren H, Liu B. 99mTc- and Re-labeled 6-dialkylamino-2-naphthylethylidene derivatives as imaging probes for β-amyloid plaques. Bioorg Med Chem Lett. 2011;21(3):1064-8.
-
(2011)
Bioorg Med Chem Lett
, vol.21
, Issue.3
, pp. 1064-1068
-
-
Cui, M.1
Tang, R.2
Li, Z.3
Ren, H.4
Liu, B.5
-
27
-
-
0026597063
-
Alzheimer's disease: The amyloid cascade hypothesis
-
Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184-5.
-
(1992)
Science
, vol.256
, Issue.5054
, pp. 184-185
-
-
Hardy, J.A.1
Higgins, G.A.2
-
28
-
-
0025908356
-
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
-
Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41(4):479-86.
-
(1991)
Neurology
, vol.41
, Issue.4
, pp. 479-486
-
-
Mirra, S.S.1
Heyman, A.2
McKeel, D.3
Sumi, S.M.4
Crain, B.J.5
Brownlee, L.M.6
-
29
-
-
0026740795
-
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
-
Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 1992;42(3 Pt 1):631-9.
-
(1992)
Neurology
, vol.42
, Issue.3 PART 1
, pp. 631-639
-
-
Arriagada, P.V.1
Growdon, J.H.2
Hedley-Whyte, E.T.3
Hyman, B.T.4
-
30
-
-
0344653664
-
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
-
Gómez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol. 1997;41(1):17-24.
-
(1997)
Ann Neurol
, vol.41
, Issue.1
, pp. 17-24
-
-
Gómez-Isla, T.1
Hollister, R.2
West, H.3
Mui, S.4
Growdon, J.H.5
Petersen, R.C.6
-
31
-
-
15144345926
-
A novel presenilin-1 mutation: Increased beta-amyloid and neurofibrillary changes
-
Gómez-Isla T, Wasco W, Pettingell WP, Gurubhagavatula S, Schmidt SD, Jondro PD et al. A novel presenilin-1 mutation: increased beta-amyloid and neurofibrillary changes. Ann Neurol. 1997;41(6):809-13.
-
(1997)
Ann Neurol
, vol.41
, Issue.6
, pp. 809-813
-
-
Gómez-Isla, T.1
Wasco, W.2
Pettingell, W.P.3
Gurubhagavatula, S.4
Schmidt, S.D.5
Jondro, P.D.6
-
32
-
-
84859482077
-
Molecular Approaches to the Treatment, Prophylaxis, and Diagnosis of Alzheimer's Disease: Novel PET/ SPECT Imaging Probes for Diagnosis of Alzheimer's Disease
-
Ono M, Saji H. Molecular Approaches to the Treatment, Prophylaxis, and Diagnosis of Alzheimer's Disease: Novel PET/ SPECT Imaging Probes for Diagnosis of Alzheimer's Disease. J Pharmacol Sci. 2012;344(338):338-44.
-
(2012)
J Pharmacol Sci
, vol.344
, Issue.338
, pp. 338-344
-
-
Ono, M.1
Saji, H.2
-
33
-
-
0035893245
-
Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease
-
Agdeppa ED, Kepe V, Liu J, Flores-Torres S, Satyamurthy N, Petric A et al. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. J Neurosci. 2001;21(24):RC189.
-
(2001)
J Neurosci
, vol.21
, Issue.24
-
-
Agdeppa, E.D.1
Kepe, V.2
Liu, J.3
Flores-Torres, S.4
Satyamurthy, N.5
Petric, A.6
-
34
-
-
84903202261
-
Localization of neurofibrillary tangles and betaamyloid plaques in the brains of living patients with Alzheimer disease
-
Shoghi-Jadid K, Small GW, Agdeppa ED, Kepe V, Ercoli LM, Siddarth P et al. Localization of neurofibrillary tangles and betaamyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry. 2002;10(1):24-35.
-
(2002)
Am J Geriatr Psychiatry
, vol.10
, Issue.1
, pp. 24-35
-
-
Shoghi-Jadid, K.1
Small, G.W.2
Agdeppa, E.D.3
Kepe, V.4
Ercoli, L.M.5
Siddarth, P.6
-
35
-
-
40149109154
-
Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans,trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene]
-
Velasco A, Fraser G, Delobel P, Ghetti B, Lavenir I, Goedert M. Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans,trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene]. FEBS lett. 2008;582(6):901-6.
-
(2008)
FEBS Lett
, vol.582
, Issue.6
, pp. 901-906
-
-
Velasco, A.1
Fraser, G.2
Delobel, P.3
Ghetti, B.4
Lavenir, I.5
Goedert, M.6
-
36
-
-
77950811222
-
Curcumin labeling of neuronal fibrillar tau inclusions in human brain samples
-
Mohorko N, Repovs G, Popović M, Kovacs GG, Bresjanac M. Curcumin labeling of neuronal fibrillar tau inclusions in human brain samples. J Neuropathol Exp Neurol. 2010;69(4):405-14.
-
(2010)
J Neuropathol Exp Neurol
, vol.69
, Issue.4
, pp. 405-414
-
-
Mohorko, N.1
Repovs, G.2
Popović, M.3
Kovacs, G.G.4
Bresjanac, M.5
-
37
-
-
33845707784
-
PET of brain amyloid and tau in mild cognitive impairment
-
Small GW, Kepe V, Ercoli LM, Siddarth P, Bookheimer SY, Miller KJ, et al. PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med. 2006;355(25):2652-63.
-
(2006)
N Engl J Med
, vol.355
, Issue.25
, pp. 2652-2663
-
-
Small, G.W.1
Kepe, V.2
Ercoli, L.M.3
Siddarth, P.4
Bookheimer, S.Y.5
Miller, K.J.6
-
38
-
-
56249117311
-
Peripheral metabolism of [(18)F]FDDNP and cerebral uptake of its labelled metabolites
-
Luurtsema G, Schuit RC, Takkenkamp K, Lubberink M, Hendrikse NH, Windhorst AD et al. Peripheral metabolism of [(18)F]FDDNP and cerebral uptake of its labelled metabolites. Nucl Med Biol. 2008;35(8):869-74.
-
(2008)
Nucl Med Biol
, vol.35
, Issue.8
, pp. 869-874
-
-
Luurtsema, G.1
Schuit, R.C.2
Takkenkamp, K.3
Lubberink, M.4
Hendrikse, N.H.5
Windhorst, A.D.6
-
39
-
-
28044460038
-
Quinoline and benzimidazole derivatives: Candidate probes for in vivo imaging of tau pathology in Alzheimer's disease
-
Okamura N, Suemoto T, Furumoto S, Suzuki M, Shimadzu H, Akatsu H et al. Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease. J Neurosci. 2005;25(47):10857-62.
-
(2005)
J Neurosci
, vol.25
, Issue.47
, pp. 10857-10862
-
-
Okamura, N.1
Suemoto, T.2
Furumoto, S.3
Suzuki, M.4
Shimadzu, H.5
Akatsu, H.6
-
40
-
-
79953651513
-
A novel in vivo tau imaging ligand for Alzheimer's disease
-
18F-THK523
-
Fodero-Tavoletti MT, Okamura N, Furumoto S, Mulligan RS, Connor AR, McLean CA, et al. 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease. Brain. 2011;134(Pt 4):1089-100.
-
(2011)
Brain
, vol.134
, Issue.PART 4
, pp. 1089-1100
-
-
Fodero-Tavoletti, M.T.1
Okamura, N.2
Furumoto, S.3
Mulligan, R.S.4
Connor, A.R.5
McLean, C.A.6
-
41
-
-
77954315712
-
Development of dual functional SPECT/fluorescent probes for imaging cerebral beta-amyloid plaques
-
Ono M, Ishikawa M, Kimura H, Hayashi S, Matsumura K, Watanabe H et al. Development of dual functional SPECT/fluorescent probes for imaging cerebral beta-amyloid plaques. Bioorg Med Chem Lett. 2010;20(13):3885-8.
-
(2010)
Bioorg Med Chem Lett
, vol.20
, Issue.13
, pp. 3885-3888
-
-
Ono, M.1
Ishikawa, M.2
Kimura, H.3
Hayashi, S.4
Matsumura, K.5
Watanabe, H.6
-
42
-
-
36148962734
-
Differentiating Alzheimer disease-associated aggregates with small molecules
-
Honson NS, Johnson RL, Huang W, Inglese J, Austin CP, Kuret J. Differentiating Alzheimer disease-associated aggregates with small molecules. Neurobiol Dis. 2007;28(3):251-60.
-
(2007)
Neurobiol Dis
, vol.28
, Issue.3
, pp. 251-260
-
-
Honson, N.S.1
Johnson, R.L.2
Huang, W.3
Inglese, J.4
Austin, C.P.5
Kuret, J.6
-
43
-
-
81455139926
-
Interaction between α-synuclein and other proteins in neurodegenerative disorders
-
Jellinger KA. Interaction between α-synuclein and other proteins in neurodegenerative disorders. ScientificWorldJournal. 2011;11:1893-907.
-
(2011)
ScientificWorldJournal
, vol.11
, pp. 1893-1907
-
-
Jellinger, K.A.1
-
44
-
-
63449093494
-
Alpha-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity
-
Liu G, Zhang C, Yin J, Li X, Cheng F, Li Y et al. alpha-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity. Neurosci lett. 2009;454(3):187-92.
-
(2009)
Neurosci Lett
, vol.454
, Issue.3
, pp. 187-192
-
-
Liu, G.1
Zhang, C.2
Yin, J.3
Li, X.4
Cheng, F.5
Li, Y.6
-
45
-
-
84866918574
-
From α-synuclein to synaptic dysfunctions: New insights into the pathophysiology of Parkinson's disease
-
Available at, [cited 2012 Jun 25]
-
Bellucci A, Zaltieri M, Navarria L, Grigoletto J, Missale C, Spano P. From α-synuclein to synaptic dysfunctions: New insights into the pathophysiology of Parkinson's disease. Brain Res [Available at: http://www.ncbi.nlm.nih.gov/pubmed/22560500]. 2012 [cited 2012 Jun 25].
-
(2012)
Brain Res
-
-
Bellucci, A.1
Zaltieri, M.2
Navarria, L.3
Grigoletto, J.4
Missale, C.5
Spano, P.6
-
46
-
-
0037127216
-
Tubulin seeds alpha-synuclein fibril formation
-
Alim MA, Hossain MS, Arima K, Takeda K, Izumiyama Y, Nakamura M et al. Tubulin seeds alpha-synuclein fibril formation. J Biol Chem. 2002;277(3):2112-7.
-
(2002)
J Biol Chem
, vol.277
, Issue.3
, pp. 2112-2117
-
-
Alim, M.A.1
Hossain, M.S.2
Arima, K.3
Takeda, K.4
Izumiyama, Y.5
Nakamura, M.6
-
47
-
-
4644249092
-
Demonstration of a role for alpha-synuclein as a functional microtubule-associated protein
-
discussion 443-9
-
Alim MA, Ma Q-L, Takeda K, Aizawa T, Matsubara M, Nakamura M et al. Demonstration of a role for alpha-synuclein as a functional microtubule-associated protein. J Alzheimers Dis. 2004;6(4):435-42 [discussion 443-9].
-
(2004)
J Alzheimers Dis
, vol.6
, Issue.4
, pp. 435-442
-
-
Alim, M.A.1
Ma, Q.-L.2
Takeda, K.3
Aizawa, T.4
Matsubara, M.5
Nakamura, M.6
-
48
-
-
33746533924
-
Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models
-
Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B et al. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science. 2006;313(5785):324-8.
-
(2006)
Science
, vol.313
, Issue.5785
, pp. 324-328
-
-
Cooper, A.A.1
Gitler, A.D.2
Cashikar, A.3
Haynes, C.M.4
Hill, K.J.5
Bhullar, B.6
-
49
-
-
34548620297
-
Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation
-
Uversky VN. Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation. J Neurochem. 2007;103(1):17-37.
-
(2007)
J Neurochem
, vol.103
, Issue.1
, pp. 17-37
-
-
Uversky, V.N.1
-
50
-
-
34248579112
-
A novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients
-
2-(2-[2-Dimethylaminothiazol-5-yl] ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole
-
Kudo Y, Okamura N, Furumoto S, Tashiro M, Furukawa K, Maruyama M et al. 2-(2-[2-Dimethylaminothiazol-5-yl] ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agentfor in vivo detection of dense amyloid plaques in Alzheimer's disease patients. J Nucl Med. 2007;48(4):553-61.
-
(2007)
J Nucl Med
, vol.48
, Issue.4
, pp. 553-561
-
-
Kudo, Y.1
Okamura, N.2
Furumoto, S.3
Tashiro, M.4
Furukawa K.Maruyama, M.5
-
51
-
-
68549085069
-
In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies
-
Fodero-Tavoletti MT, Mulligan RS, Okamura N, Furumoto S, Rowe CC, Kudo Y et al. In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies. Eur J Pharmacol. 2009;617(1-3):54-8.
-
(2009)
Eur J Pharmacol
, vol.617
, Issue.1-3
, pp. 54-58
-
-
Fodero-Tavoletti, M.T.1
Mulligan, R.S.2
Okamura, N.3
Furumoto, S.4
Rowe, C.C.5
Kudo, Y.6
-
52
-
-
77952982672
-
In vivo visualization of alpha-synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy]benzoxazole positron emission tomography in multiple system atrophy
-
Kikuchi A, Takeda A, Okamura N, Tashiro M, Hasegawa T, Furumoto S et al. In vivo visualization of alpha-synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy]benzoxazole positron emission tomography in multiple system atrophy. Brain. 2010;133(Pt 6):1772-8.
-
(2010)
Brain
, vol.133
, Issue.PART 6
, pp. 1772-1778
-
-
Kikuchi, A.1
Takeda, A.2
Okamura, N.3
Tashiro, M.4
Hasegawa, T.5
Furumoto, S.6
-
53
-
-
80051707096
-
Neuroinflammation and ageing: Current theories and an overview of the data
-
Pizza V, Agresta A, D'Acunto CW, Festa M, Capasso A. Neuroinflammation and ageing: current theories and an overview of the data. Rev Recent Clin Trials. 2011;6(3):189-203.
-
(2011)
Rev Recent Clin Trials
, vol.6
, Issue.3
, pp. 189-203
-
-
Pizza, V.1
Agresta, A.2
D'Acunto, C.W.3
Festa, M.4
Capasso, A.5
-
54
-
-
42649115741
-
Translocator protein 18 kDa (TSPO): Molecular sensor of brain injury and repair
-
Chen M-K, Guilarte TR. Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol Ther. 2008;118(1):1-17.
-
(2008)
Pharmacol Ther
, vol.118
, Issue.1
, pp. 1-17
-
-
Chen, M.-K.1
Guilarte, T.R.2
-
55
-
-
13144258735
-
Microglial activation and dopamine terminal loss in early Parkinson's disease
-
Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T et al. Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann Neurol. 2005;57(2):168-75.
-
(2005)
Ann Neurol
, vol.57
, Issue.2
, pp. 168-175
-
-
Ouchi, Y.1
Yoshikawa, E.2
Sekine, Y.3
Futatsubashi, M.4
Kanno, T.5
Ogusu, T.6
-
56
-
-
79551531674
-
In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease
-
Yokokura M, Mori N, Yagi S, Yoshikawa E, Kikuchi M, Yoshihara Y et al. In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2011;38(2):343-51.
-
(2011)
Eur J Nucl Med Mol Imaging
, vol.38
, Issue.2
, pp. 343-351
-
-
Yokokura, M.1
Mori, N.2
Yagi, S.3
Yoshikawa, E.4
Kikuchi, M.5
Yoshihara, Y.6
-
57
-
-
0035845283
-
In-vivo measurement of activated microglia in dementia
-
Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE et al. In-vivo measurement of activated microglia in dementia. Lancet. 2001;358(9280):461-7.
-
(2001)
Lancet
, vol.358
, Issue.9280
, pp. 461-467
-
-
Cagnin, A.1
Brooks, D.J.2
Kennedy, A.M.3
Gunn, R.N.4
Myers, R.5
Turkheimer, F.E.6
-
58
-
-
9644254411
-
In vivo detection of microglial activation in frontotemporal dementia
-
Cagnin A, Rossor M, Sampson EL, Mackinnon T, Banati RB. In vivo detection of microglial activation in frontotemporal dementia. Ann Neurol. 2004;56(6):894-7.
-
(2004)
Ann Neurol
, vol.56
, Issue.6
, pp. 894-897
-
-
Cagnin, A.1
Rossor, M.2
Sampson, E.L.3
Mackinnon, T.4
Banati, R.B.5
-
59
-
-
51149120624
-
Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice
-
Hickman SE, Allison EK, El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci. 2008;28(33):8354-60.
-
(2008)
J Neurosci
, vol.28
, Issue.33
, pp. 8354-8360
-
-
Hickman, S.E.1
Allison, E.K.2
El Khoury, J.3
-
60
-
-
67649101348
-
Imaging microglial activation during neuroinflammation and Alzheimer's disease
-
Venneti S, Wiley CA, Kofler J. Imaging microglial activation during neuroinflammation and Alzheimer's disease. J Neuroimmune Pharmacol. 2009;4(2):227-43.
-
(2009)
J Neuroimmune Pharmacol
, vol.4
, Issue.2
, pp. 227-243
-
-
Venneti, S.1
Wiley, C.A.2
Kofler, J.3
-
61
-
-
84865624449
-
Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases
-
Ching ASC, Kuhnast B, Damont A, Roeda D, Tavitian B, Dollé F. Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases. Insights Imaging. 2011;3(1):111-9.
-
(2011)
Insights Imaging
, vol.3
, Issue.1
, pp. 111-119
-
-
Ching, A.S.C.1
Kuhnast, B.2
Damont, A.3
Roeda, D.4
Tavitian, B.5
Dollé, F.6
-
63
-
-
34248529814
-
A novel peripheral benzodiazepine receptor PET ligand for in vivo imaging of neuroinflammation
-
11C-DPA-713
-
Boutin H, Chauveau F, Thominiaux C, Grégoire M-C, James ML, Trebossen R, et al. 11C-DPA-713: a novel peripheral benzodiazepine receptor PET ligand for in vivo imaging of neuroinflammation. J Nucl Med. 2007;48(4):573-81.
-
(2007)
J Nucl Med
, vol.48
, Issue.4
, pp. 573-581
-
-
Boutin, H.1
Chauveau, F.2
Thominiaux, C.3
Grégoire, M.-C.4
James M.L.Trebossen, R.5
-
64
-
-
77952093172
-
In vivo imaging of neuroinflammation: A comparative study between [(18)F]PBR111, [ (11)C]CLINME and [ (11)C] PK11195 in an acute rodent model
-
Van Camp N, Boisgard R, Kuhnast B, Thézé B, Viel T, Grégoire M-C, et al. In vivo imaging of neuroinflammation: a comparative study between [(18)F]PBR111, [ (11)C]CLINME and [ (11)C] PK11195 in an acute rodent model. Eur J Nucl Med Mol Imaging. 2010;37(5):962-72.
-
(2010)
Eur J Nucl Med Mol Imaging
, vol.37
, Issue.5
, pp. 962-972
-
-
van Camp, N.1
Boisgard, R.2
Kuhnast, B.3
Thézé, B.4
Viel, T.5
Grégoire, M.-C.6
-
66
-
-
84863022896
-
Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide
-
Tang D, Hight MR, McKinley ET, Fu A, Buck JR, Smith RA et al. Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide. J Nucl Med. 2012;53(2):287-94.
-
(2012)
J Nucl Med
, vol.53
, Issue.2
, pp. 287-294
-
-
Tang, D.1
Hight, M.R.2
McKinley, E.T.3
Fu, A.4
Buck, J.R.5
Smith, R.A.6
-
67
-
-
84862581540
-
The translocator protein ligand [(18)F]DPA-714 images glioma and activated microglia in vivo
-
Winkeler A, Boisgard R, Awde AR, Dubois A, Thézé B, Zheng J et al. The translocator protein ligand [(18)F]DPA-714 images glioma and activated microglia in vivo. Eur J Nucl Med Mol Imaging. 2012;39(5):811-23.
-
(2012)
Eur J Nucl Med Mol Imaging
, vol.39
, Issue.5
, pp. 811-823
-
-
Winkeler, A.1
Boisgard, R.2
Awde, A.R.3
Dubois, A.4
Thézé, B.5
Zheng, J.6
-
68
-
-
84858596901
-
-
18F-FEAnGA for PET of β-glucuronidase activity in neuroinflammation
-
Antunes IF, Doorduin J, Haisma HJ, Elsinga PH, van Waarde A, Willemsen ATM et al. 18F-FEAnGA for PET of β-glucuronidase activity in neuroinflammation. J Nucl Med. 2012;53(3):451-8.
-
(2012)
J Nucl Med
, vol.53
, Issue.3
, pp. 451-458
-
-
Antunes, I.F.1
Doorduin, J.2
Haisma, H.J.3
Elsinga, P.H.4
van Waarde A.Willemsen, A.T.M.5
-
70
-
-
0032799421
-
Inhibition of central monoamine oxidase by imidazoline2 site-selective ligands
-
Lalies MD, Hibell A, Hudson AL, Nutt DJ. Inhibition of central monoamine oxidase by imidazoline2 site-selective ligands. Ann N Y Acad Sci. 1999;881:114-7.
-
(1999)
Ann N Y Acad Sci
, vol.881
, pp. 114-117
-
-
Lalies, M.D.1
Hibell, A.2
Hudson, A.L.3
Nutt, D.J.4
-
73
-
-
84859426428
-
Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand, BU99008 (2-(4,5-dihydro-1H-imidazol-2-yl)-1- methyl-1H-indole), for the imidazoline{ballot box} binding site
-
Tyacke RJ, Fisher A, Robinson ESJ, Grundt P, Turner EM, Husbands SM et al. Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand, BU99008 (2-(4,5-dihydro-1H-imidazol-2-yl)-1- methyl-1H-indole), for the imidazoline{ballot box} binding site. Synapse. 2012;66(6):542-51.
-
(2012)
Synapse
, vol.66
, Issue.6
, pp. 542-551
-
-
Tyacke, R.J.1
Fisher, A.2
Robinson, E.S.J.3
Grundt, P.4
Turner, E.M.5
Husbands, S.M.6
-
74
-
-
79960336672
-
In vivo expression of cyclooxygenase-1 in activated microglia and macrophages during neuroinflammation visualized by PET with 11C-ketoprofen methyl ester
-
Shukuri M, Takashima-Hirano M, Tokuda K, Takashima T, Matsumura K, Inoue O et al. In vivo expression of cyclooxygenase-1 in activated microglia and macrophages during neuroinflammation visualized by PET with 11C-ketoprofen methyl ester. J Nucl Med. 2011;52(7):1094-101.
-
(2011)
J Nucl Med
, vol.52
, Issue.7
, pp. 1094-1101
-
-
Shukuri, M.1
Takashima-Hirano, M.2
Tokuda, K.3
Takashima, T.4
Matsumura, K.5
Inoue, O.6
-
75
-
-
84855369203
-
Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: A multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG
-
Carter SF, Schöll M, Almkvist O, Wall A, Engler H, Långström B et al. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. J Nucl Med. 2012;53(1):37-46.
-
(2012)
J Nucl Med
, vol.53
, Issue.1
, pp. 37-46
-
-
Carter, S.F.1
Schöll, M.2
Almkvist, O.3
Wall, A.4
Engler, H.5
Långström, B.6
-
76
-
-
84856235427
-
In vivo imaging of astrocytosis in Alzheimer's disease: An 11C-L-deuteriodeprenyl and PIB PET study
-
Santillo AF, Gambini JP, Lannfelt L, Långström B, Ulla-Marja L, Kilander L et al. In vivo imaging of astrocytosis in Alzheimer's disease: an 11C-L-deuteriodeprenyl and PIB PET study. Eur J Nucl Med Mol Imaging. 2011;38(12):2202-8.
-
(2011)
Eur J Nucl Med Mol Imaging
, vol.38
, Issue.12
, pp. 2202-2208
-
-
Santillo, A.F.1
Gambini, J.P.2
Lannfelt, L.3
Långström, B.4
Ulla-Marja, L.5
Kilander, L.6
-
77
-
-
0038307374
-
Assessment of neuroinflammation and microglial activation in Alzheimer's disease with radiolabelled PK11195 and single photon emission computed tomography. A pilot study
-
Versijpt JJ, Dumont F, Van Laere KJ, Decoo D, Santens P, Audenaert K et al. Assessment of neuroinflammation and microglial activation in Alzheimer's disease with radiolabelled PK11195 and single photon emission computed tomography. A pilot study. Eur Neurol. 2003;50(1):39-47.
-
(2003)
Eur Neurol
, vol.50
, Issue.1
, pp. 39-47
-
-
Versijpt, J.J.1
Dumont, F.2
van Laere, K.J.3
Decoo, D.4
Santens, P.5
Audenaert, K.6
-
78
-
-
58149305696
-
Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation
-
Arlicot N, Katsifis A, Garreau L, Mattner F, Vergote J, Duval S et al. Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation. Eur J Nucl Med Mol Imaging. 2008;35(12):2203-11.
-
(2008)
Eur J Nucl Med Mol Imaging
, vol.35
, Issue.12
, pp. 2203-2211
-
-
Arlicot, N.1
Katsifis, A.2
Garreau, L.3
Mattner, F.4
Vergote, J.5
Duval, S.6
-
79
-
-
80052566963
-
Evaluation of [123I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation
-
Mattner F, Bandin DL, Staykova M, Berghofer P, Gregoire MC, Ballantyne P et al. Evaluation of [123I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation. Eur J Nucl Med Mol Imaging. 2011;38(8):1516-28.
-
(2011)
Eur J Nucl Med Mol Imaging
, vol.38
, Issue.8
, pp. 1516-1528
-
-
Mattner, F.1
Bandin, D.L.2
Staykova, M.3
Berghofer, P.4
Gregoire, M.C.5
Ballantyne, P.6
-
80
-
-
70349155429
-
Synthesis of [(125)I]iodoDPA-713: A new probe for imaging inflammation
-
Wang H, Pullambhatla M, Guilarte TR, Mease RC, Pomper MG. Synthesis of [(125)I]iodoDPA-713: a new probe for imaging inflammation. Biochem Biophys Res Commun. 2009;389(1):80-3.
-
(2009)
Biochem Biophys Res Commun
, vol.389
, Issue.1
, pp. 80-83
-
-
Wang, H.1
Pullambhatla, M.2
Guilarte, T.R.3
Mease, R.C.4
Pomper, M.G.5
-
81
-
-
67449127220
-
Whole-body synthesis-secretion rates of long-chain n-3 PUFAs from circulating unesterified alpha-linolenic acid in unanesthetized rats
-
Gao F, Kiesewetter D, Chang L, Ma K, Bell JM, Rapoport SI et al. Whole-body synthesis-secretion rates of long-chain n-3 PUFAs from circulating unesterified alpha-linolenic acid in unanesthetized rats. J Lipid Res. 2009;50(4):749-58.
-
(2009)
J Lipid Res
, vol.50
, Issue.4
, pp. 749-758
-
-
Gao, F.1
Kiesewetter, D.2
Chang, L.3
Ma, K.4
Bell, J.M.5
Rapoport, S.I.6
-
82
-
-
57349111168
-
Arachidonic acid and the brain
-
Rapoport SI. Arachidonic acid and the brain. J Nutr. 2008;138(12):2515-20.
-
(2008)
J Nutr
, vol.138
, Issue.12
, pp. 2515-2520
-
-
Rapoport, S.I.1
-
83
-
-
77949680686
-
Lipid-mediated cell signaling protects against injury and neurodegeneration
-
Zhang C, Bazan NG. Lipid-mediated cell signaling protects against injury and neurodegeneration. J Nutr. 2010;140(4):858-63.
-
(2010)
J Nutr
, vol.140
, Issue.4
, pp. 858-863
-
-
Zhang, C.1
Bazan, N.G.2
-
84
-
-
80052477281
-
Inhibition of phospholipase A(2) in rat brain decreases the levels of total Tau protein
-
Schaeffer EL, De-Paula VJ, da Silva ER, de A Novaes B, Skaf HD, Forlenza OV et al. Inhibition of phospholipase A(2) in rat brain decreases the levels of total Tau protein. J Neural Transm. 2011;118(9):1273-9.
-
(2011)
J Neural Transm
, vol.118
, Issue.9
, pp. 1273-1279
-
-
Schaeffer, E.L.1
De-Paula, V.J.2
da Silva, E.R.3
de A Novaes, B.4
Skaf, H.D.5
Forlenza, O.V.6
-
85
-
-
80054857565
-
Endogenous signaling by omega-3 docosahexaenoic acid-derived mediators sustains homeostatic synaptic and circuitry integrity
-
Bazan NG, Musto AE, Knott EJ. Endogenous signaling by omega-3 docosahexaenoic acid-derived mediators sustains homeostatic synaptic and circuitry integrity. Mol Neurobiol. 2011;44(2):216-22.
-
(2011)
Mol Neurobiol
, vol.44
, Issue.2
, pp. 216-222
-
-
Bazan, N.G.1
Musto, A.E.2
Knott, E.J.3
-
86
-
-
79960533372
-
Docosahexaenoic acid signalolipidomics in nutrition: Significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases
-
Bazan NG, Molina MF, Gordon WC. Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. Annu Rev Nutr. 2011;31:321-51.
-
(2011)
Annu Rev Nutr
, vol.31
, pp. 321-351
-
-
Bazan, N.G.1
Molina, M.F.2
Gordon, W.C.3
-
87
-
-
81155134068
-
Docosahexaenoic acid (DHA) incorporation into the brain from plasma, as an in vivo biomarker of brain DHA metabolism and neurotransmission
-
Rapoport SI, Ramadan E, Basselin M. Docosahexaenoic acid (DHA) incorporation into the brain from plasma, as an in vivo biomarker of brain DHA metabolism and neurotransmission. Prostaglandins Other Lipid Mediat. 2011;96(1-4):109-13.
-
(2011)
Prostaglandins Other Lipid Mediat
, vol.96
, Issue.1-4
, pp. 109-113
-
-
Rapoport, S.I.1
Ramadan, E.2
Basselin, M.3
-
88
-
-
51349124394
-
Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET
-
Esposito G, Giovacchini G, Liow J-S, Bhattacharjee AK, Greenstein D, Schapiro M et al. Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET. J Nucl Med. 2008;49(9):1414-21.
-
(2008)
J Nucl Med
, vol.49
, Issue.9
, pp. 1414-1421
-
-
Esposito, G.1
Giovacchini, G.2
Liow, J.-S.3
Bhattacharjee, A.K.4
Greenstein, D.5
Schapiro, M.6
-
89
-
-
0033954765
-
Polyunsaturated fatty acids in the food chain in the United States
-
Kris-Etherton PM, Taylor DS, Yu-Poth S, Huth P, Moriarty K, Fishell V et al. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr. 2000;71(1 Suppl):179S-88S.
-
(2000)
Am J Clin Nutr
, vol.71
, Issue.SUPPL. 1
-
-
Kris-Etherton, P.M.1
Taylor, D.S.2
Yu-Poth, S.3
Huth, P.4
Moriarty, K.5
Fishell, V.6
-
90
-
-
67650529118
-
Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography
-
Umhau JC, Zhou W, Carson RE, Rapoport SI, Polozova A, Demar J et al. Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography. J Lipid Res. 2009;50(7):1259-68.
-
(2009)
J Lipid Res
, vol.50
, Issue.7
, pp. 1259-1268
-
-
Umhau, J.C.1
Zhou, W.2
Carson, R.E.3
Rapoport, S.I.4
Polozova, A.5
Demar, J.6
-
91
-
-
0034500422
-
Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment
-
Conquer JA, Tierney MC, Zecevic J, Bettger WJ, Fisher RH. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids. 2000;35(12):1305-12.
-
(2000)
Lipids
, vol.35
, Issue.12
, pp. 1305-1312
-
-
Conquer, J.A.1
Tierney, M.C.2
Zecevic, J.3
Bettger, W.J.4
Fisher, R.H.5
-
92
-
-
78049407029
-
Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: A randomized trial
-
Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA. 2010;304(17):1903-11.
-
(2010)
JAMA
, vol.304
, Issue.17
, pp. 1903-1911
-
-
Quinn, J.F.1
Raman, R.2
Thomas, R.G.3
Yurko-Mauro, K.4
Nelson, E.B.5
van Dyck, C.6
-
93
-
-
0032542958
-
Fish consumption and major depression
-
Hibbeln JR. Fish consumption and major depression. Lancet. 1998;351(9110):1213.
-
(1998)
Lancet
, vol.351
, Issue.9110
, pp. 1213
-
-
Hibbeln, J.R.1
-
94
-
-
79952456012
-
-
11 C] enzastaurin, the first design and radiosynthesis of a new potential PET agent for imaging of protein kinase C
-
11 C] enzastaurin, the first design and radiosynthesis of a new potential PET agent for imaging of protein kinase C. Bioorg Med Chem Lett. 2011;21(6):1649-53.
-
(2011)
Bioorg Med Chem Lett
, vol.21
, Issue.6
, pp. 1649-1653
-
-
Wang, M.1
Xu, L.2
Gao, M.3
Miller, K.D.4
Sledge G.W.Zheng, Q.-H.5
-
95
-
-
67749147448
-
Searching for disease modifiers-PKC activation and HDAC inhibition - a dual drug approach to Alzheimer's diseasethat decreases Abeta production while blocking oxidative stress
-
Kozikowski AP, Chen Y, Subhasish T, Lewin NE, Blumberg PM, Zhong Z et al. Searching for disease modifiers-PKC activation and HDAC inhibition - a dual drug approach to Alzheimer's diseasethat decreases Abeta production while blocking oxidative stress. ChemMedChem. 2009;4(7):1095-105.
-
(2009)
ChemMedChem
, vol.4
, Issue.7
, pp. 1095-1105
-
-
Kozikowski, A.P.1
Chen, Y.2
Subhasish, T.3
Lewin, N.E.4
Blumberg, P.M.5
Zhong, Z.6
-
96
-
-
78649449000
-
A novel PET marker for in vivo quantification of myelination
-
Wu C, Wang C, Popescu DC, Zhu W, Somoza EA, Zhu J et al. A novel PET marker for in vivo quantification of myelination. Bioorg Med Chem. 2010;18(24):8592-9.
-
(2010)
Bioorg Med Chem
, vol.18
, Issue.24
, pp. 8592-8599
-
-
Wu, C.1
Wang, C.2
Popescu, D.C.3
Zhu, W.4
Somoza, E.A.5
Zhu, J.6
-
97
-
-
79956198149
-
Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease
-
Lassmann H. Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease. J Neural Transm. 2011;118(5):747-52.
-
(2011)
J Neural Transm
, vol.118
, Issue.5
, pp. 747-752
-
-
Lassmann, H.1
-
98
-
-
75149142186
-
Hsp70 molecular chaperones and Parkinson's disease
-
Witt SN. Hsp70 molecular chaperones and Parkinson's disease. Biopolymers. 2010;93(3):218-28.
-
(2010)
Biopolymers
, vol.93
, Issue.3
, pp. 218-228
-
-
Witt, S.N.1
-
99
-
-
0032576605
-
Aggresomes: A cellular response to misfolded proteins
-
Johnston JA, Ward CL, Kopito RR. Aggresomes: a cellular response to misfolded proteins. J Cell Biol. 1998;143(7):1883-98.
-
(1998)
J Cell Biol
, vol.143
, Issue.7
, pp. 1883-1898
-
-
Johnston, J.A.1
Ward, C.L.2
Kopito, R.R.3
-
100
-
-
84861213255
-
Cathepsins L and Z Are Critical in Degrading Polyglutaminecontaining Proteins within Lysosomes
-
Bhutani N, Piccirillo R, Hourez R, Venkatraman P, Goldberg AL. Cathepsins L and Z Are Critical in Degrading Polyglutaminecontaining Proteins within Lysosomes. J Biol Chem. 2012;287(21):17471-82.
-
(2012)
J Biol Chem
, vol.287
, Issue.21
, pp. 17471-17482
-
-
Bhutani, N.1
Piccirillo, R.2
Hourez, R.3
Venkatraman, P.4
Goldberg, A.L.5
-
101
-
-
84857315582
-
Monitoring the induction of heat shock factor 1/ heat shock protein 70 expression following 17-allylaminodemethoxygeldanamycin treatment by positron emission tomography and optical reporter gene imaging
-
Doubrovin M, Che JT, Serganova I, Moroz E, Solit DB, Ageyeva L et al. Monitoring the induction of heat shock factor 1/ heat shock protein 70 expression following 17-allylaminodemethoxygeldanamycin treatment by positron emission tomography and optical reporter gene imaging. Mol Imaging. 2012;11(1):67-76.
-
(2012)
Mol Imaging
, vol.11
, Issue.1
, pp. 67-76
-
-
Doubrovin, M.1
Che, J.T.2
Serganova, I.3
Moroz, E.4
Solit, D.B.5
Ageyeva, L.6
-
102
-
-
84865563936
-
Hematopoietic MyD88-adaptor Protein Acts as a Natural Defense Mechanism for Cognitive Deficits in Alzheimer's Disease
-
Available at, cited 2012 May 17
-
Michaud J-P, Richard KL, Rivest S. Hematopoietic MyD88-adaptor Protein Acts as a Natural Defense Mechanism for Cognitive Deficits in Alzheimer's Disease. Stem Cell Rev [Available at: http://www.ncbi.nlm.nih.gov/pubmed/22374079]. 2012 [cited 2012 May 17].
-
(2012)
Stem Cell Rev
-
-
Michaud, J.-P.1
Richard, K.L.2
Rivest, S.3
-
103
-
-
79960282591
-
The critical role of the MyD88-dependent pathway in non-CNS MPTP-mediated toxicity
-
Côté M, Drouin-Ouellet J, Cicchetti F, Soulet D. The critical role of the MyD88-dependent pathway in non-CNS MPTP-mediated toxicity. Brain Behav Immun. 2011;25(6):1143-52.
-
(2011)
Brain Behav Immun
, vol.25
, Issue.6
, pp. 1143-1152
-
-
Côté, M.1
Drouin-Ouellet, J.2
Cicchetti, F.3
Soulet, D.4
-
104
-
-
80053634031
-
The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration
-
Drouin-Ouellet J, Gibrat C, Bousquet M, Calon F, Kriz J, Cicchetti F. The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration. J Neuroinflammation. 2011;8:137.
-
(2011)
J Neuroinflammation
, vol.8
, pp. 137
-
-
Drouin-Ouellet, J.1
Gibrat, C.2
Bousquet, M.3
Calon, F.4
Kriz, J.5
Cicchetti, F.6
-
105
-
-
84859598872
-
Biology of mitochondria in neurodegenerative diseases
-
Martin LJ. Biology of mitochondria in neurodegenerative diseases. Prog Mol Biol Transl Sci. 2012;107:355-415.
-
(2012)
Prog Mol Biol Transl Sci
, vol.107
, pp. 355-415
-
-
Martin, L.J.1
-
106
-
-
84857116578
-
Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
-
Ray PD, Huang B-W, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012;24(5):981-90.
-
(2012)
Cell Signal
, vol.24
, Issue.5
, pp. 981-990
-
-
Ray, P.D.1
Huang, B.-W.2
Tsuji, Y.3
-
107
-
-
84863761145
-
Radiolabelled Agents for PET Imaging of Tumor Hypoxia
-
Available at, cited 2012 Jun 11
-
Kurihara H, Honda N, Kono Y, Arai Y. Radiolabelled Agents for PET Imaging of Tumor Hypoxia. Curr Med Chem [Available at: http://www.ncbi.nlm.nih.gov/pubmed/22664246]. 2012 [cited 2012 Jun 11].
-
(2012)
Curr Med Chem
-
-
Kurihara, H.1
Honda, N.2
Kono, Y.3
Arai, Y.4
-
108
-
-
80053605315
-
Evaluation of striatal oxidative stress in patients with Parkinson's disease using [62Cu]ATSM PET
-
Ikawa M, Okazawa H, Kudo T, Kuriyama M, Fujibayashi Y, Yoneda M. Evaluation of striatal oxidative stress in patients with Parkinson's disease using [62Cu]ATSM PET. Nucl Med Biol. 2011;38(7):945-51.
-
(2011)
Nucl Med Biol
, vol.38
, Issue.7
, pp. 945-951
-
-
Ikawa, M.1
Okazawa, H.2
Kudo, T.3
Kuriyama, M.4
Fujibayashi, Y.5
Yoneda, M.6
-
109
-
-
84856333052
-
Radiolabeled Cu-ATSM as a novel indicator of overreduced intracellular state due to mitochondrial dysfunction: Studies with mitochondrial DNA-less ρ0 cells and cybrids carrying MELAS mitochondrial DNA mutation
-
Yoshii Y, Yoneda M, Ikawa M, Furukawa T, Kiyono Y, Mori T et al. Radiolabeled Cu-ATSM as a novel indicator of overreduced intracellular state due to mitochondrial dysfunction: studies with mitochondrial DNA-less ρ0 cells and cybrids carrying MELAS mitochondrial DNA mutation. Nucl Med Biol. 2012;39(2):177-85.
-
(2012)
Nucl Med Biol
, vol.39
, Issue.2
, pp. 177-185
-
-
Yoshii, Y.1
Yoneda, M.2
Ikawa, M.3
Furukawa, T.4
Kiyono, Y.5
Mori, T.6
-
110
-
-
0038241171
-
Polymorphism in the P-glycoprotein drug transporter MDR1 gene: A possible link between environmental and genetic factors in Parkinson's disease
-
Droździk M, Biatecka M, Myśliwiec K, Honczarenko K, Stankiewicz J, Sych Z. Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease. Pharmacogenetics. 2003;13(5):259-63.
-
(2003)
Pharmacogenetics
, vol.13
, Issue.5
, pp. 259-263
-
-
Droździk, M.1
Biatecka, M.2
Myśliwiec, K.3
Honczarenko, K.4
Stankiewicz, J.5
Sych, Z.6
-
111
-
-
13144255682
-
Blood-brain barrier dysfunction in parkinsonian midbrain in vivo
-
Kortekaas R, Leenders KL, van Oostrom JCH, Vaalburg W, Bart J, Willemsen ATM et al. Blood-brain barrier dysfunction in parkinsonian midbrain in vivo. Ann Neurol. 2005;57(2):176-9.
-
(2005)
Ann Neurol
, vol.57
, Issue.2
, pp. 176-179
-
-
Kortekaas, R.1
Leenders, K.L.2
van Oostrom, J.C.H.3
Vaalburg, W.4
Bart, J.5
Willemsen, A.T.M.6
-
112
-
-
0036797713
-
Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans
-
Vogelgesang S, Cascorbi I, Schroeder E, Pahnke J, Kroemer HK, Siegmund W et al. Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans. Pharmacogenetics. 2002;12(7):535-41.
-
(2002)
Pharmacogenetics
, vol.12
, Issue.7
, pp. 535-541
-
-
Vogelgesang, S.1
Cascorbi, I.2
Schroeder, E.3
Pahnke, J.4
Kroemer, H.K.5
Siegmund, W.6
-
113
-
-
70049084419
-
Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: A possible role in progressive neurodegeneration
-
Bartels AL, Kortekaas R, Bart J, Willemsen ATM, de Klerk OL, de Vries JJ et al. Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration. Neurobiol Aging. 2009;30(11):1818-24.
-
(2009)
Neurobiol Aging
, vol.30
, Issue.11
, pp. 1818-1824
-
-
Bartels, A.L.1
Kortekaas, R.2
Bart, J.3
Willemsen, A.T.M.4
de Klerk, O.L.5
de Vries, J.J.6
-
115
-
-
84860344567
-
Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease
-
Donovan LE, Higginbotham L, Dammer EB, Gearing M, Rees HD, Xia Q et al. Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease. Proteomics Clin Appl. 2012;6(3-4):201-11.
-
(2012)
Proteomics Clin Appl
, vol.6
, Issue.3-4
, pp. 201-211
-
-
Donovan, L.E.1
Higginbotham, L.2
Dammer, E.B.3
Gearing, M.4
Rees, H.D.5
Xia, Q.6
-
116
-
-
77953068390
-
Synergistic Interactions between Abeta, tau, and alphasynuclein: Acceleration of neuropathology and cognitive decline
-
Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM. Synergistic Interactions between Abeta, tau, and alphasynuclein: acceleration of neuropathology and cognitive decline. J Neurosci. 2010;30(21):7281-9.
-
(2010)
J Neurosci
, vol.30
, Issue.21
, pp. 7281-7289
-
-
Clinton, L.K.1
Blurton-Jones, M.2
Myczek, K.3
Trojanowski, J.Q.4
Laferla, F.M.5
-
117
-
-
84877987417
-
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: More to Come?
-
Available at, cited 2012 Jun 22
-
Zetterberg H, Blennow K. Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: More to Come? J Alzheimers Dis [Available at: http://www.ncbi.nlm.nih.gov/pubmed/22710917]. 2012 [cited 2012 Jun 22].
-
(2012)
J Alzheimers Dis
-
-
Zetterberg, H.1
Blennow, K.2
|